Pathway names | P value | p.adjust | qvalue | count |
---|---|---|---|---|
Fluid shear stress and atherosclerosis | 4.55E-09 | 7.19E-07 | 3.11E-07 | 8 |
AGE-RAGE signaling pathway in diabetic complications | 1.19E-08 | 9.44E-07 | 4.09E-07 | 7 |
IL-17 signaling pathway | 2.69E-07 | 1.20E-05 | 5.19E-06 | 6 |
Malaria | 3.03E-07 | 1.20E-05 | 5.19E-06 | 5 |
HIF-1 signaling pathway | 4.16E-07 | 1.31E-05 | 5.69E-06 | 6 |
TNF signaling pathway | 7.32E-07 | 1.83E-05 | 7.93E-06 | 6 |
Toxoplasmosis | 8.58E-07 | 1.83E-05 | 7.93E-06 | 6 |
Kaposi sarcoma-associated herpesvirus infection | 9.27E-07 | 1.83E-05 | 7.93E-06 | 7 |
Proteoglycans in cancer | 1.56E-06 | 2.75E-05 | 1.19E-05 | 7 |
Leishmaniasis | 2.44E-06 | 3.85E-05 | 1.67E-05 | 5 |
Pertussis | 2.78E-06 | 4.00E-05 | 1.73E-05 | 5 |
African trypanosomiasis | 3.36E-06 | 4.33E-05 | 1.87E-05 | 4 |
Hepatitis B | 3.56E-06 | 4.33E-05 | 1.87E-05 | 6 |
PI3K-Akt signaling pathway | 6.16E-06 | 6.95E-05 | 3.01E-05 | 8 |
Small cell lung cancer | 7.57E-06 | 7.97E-05 | 3.45E-05 | 5 |
Amoebiasis | 8.84E-06 | 8.73E-05 | 3.78E-05 | 5 |
Tuberculosis | 1.25E-05 | 0.000116364 | 5.04E-05 | 6 |
Amyotrophic lateral sclerosis (ALS) | 1.55E-05 | 0.000136143 | 5.90E-05 | 4 |
MicroRNAs in cancer | 2.16E-05 | 0.000179924 | 7.79E-05 | 7 |
Inflammatory bowel disease (IBD) | 4.08E-05 | 0.000322609 | 0.000139704 | 4 |